论文部分内容阅读
质子泵抑制剂(PPI)是目前治疗反流性食管炎(RE)最有效的药物之一,埃索美拉唑是新一代PPI,其控制胃酸分泌的能力比其它PPI作用更强、更快,且持续时间更长,用于治疗RE取得较好的临床效果。本观察旨在通过埃索美拉唑与兰索拉唑治疗RE的疗效比对,探索埃索美拉唑治疗RE的临床应用价值。
Proton pump inhibitor (PPI) is currently one of the most effective drugs for the treatment of reflux esophagitis (RE), a new generation of PPI that exerts more potent and faster gastric acid secretion than other PPIs , And longer duration, for the treatment of RE to achieve better clinical results. The purpose of this observation is to compare the efficacy of esomeprazole and lansoprazole in the treatment of RE and explore the clinical value of esomeprazole in the treatment of RE.